1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZSCAN2 CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA NINL CTRPv2 pan-cancer AAC 0.19 5e-09
mRNA LRRC34 CTRPv2 pan-cancer AAC 0.19 5e-09
mRNA ZNF529 CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA FAM171A2 CTRPv2 pan-cancer AAC 0.21 5e-09
mRNA SP4 CTRPv2 pan-cancer AAC 0.19 6e-09
mRNA KCNH3 CTRPv2 pan-cancer AAC 0.18 6e-09
mRNA RP11-1212A22.4 CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA BSN CTRPv2 pan-cancer AAC 0.21 6e-09
mRNA YLPM1 CTRPv2 pan-cancer AAC 0.19 6e-09
Download CSV